Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 16Male Urogenital Diseases 3Prostatic Intraepithelial Neoplasia 2Uremia 1Prostatic Hyperplasia 1Neoplasms 1Neoplasm Metastasis 1Disease Progression 1Carcinoma, Transitional Cell 1

Interventions

padeliporfin 5Lycopene 3pembrolizumab 2darolutamide 2Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1palladium-bacteriopheophorbide 1olaparib 1gedatolisib 1enfortumab vedotin 1Therapeutics 1Sugars 1Radiation Dose Hypofractionation 1Pluvicto 1Nivolumab 1Mitomycin 1Intraoperative Neurophysiological Monitoring 1Gemcitabine 1Fluorouracil 1Cisplatin 1CP protocol 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Male Urogenital Diseases × Lycopene × Genitourinary × Clear all
NCT01443026 2019-11-19

The Effects of Lycopene on High Risk Prostatic Tissue

University of Illinois at Chicago

Phase 2 Completed
66 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia, Male Urogenital Diseases

NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡